Skip to main content

Floragenex, NCGR Team on Crop Marker Collaboration

NEW YORK (GenomeWeb News) – Floragenex today announced that it is collaborating with the non-profit National Center for Genome Resources to provide services for customers with a specific focus on discovering new markers in crops.

The collaboration will partner Floragenex's genomic discovery and application tools with NCGR's Illumina sequencing and bioinformatics capabilities.

"The costs and capabilities of DNA sequencing are now reaching the threshold where a new segment of agricultural companies and academic researchers are looking to apply the tools of genomics to their breeding and research activities," Floragenex CEO Nathan Lillegard said in a statement. "Working with NCGR gives Floragenex a collaborative technology partner that brings world class capabilities to the challenges of genetic discovery for our customers."

Floragenex is based in Eugene, Ore., and is a spinout of the University of Oregon.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.